Development of the global in vitro diagnostics industry
Development of the global in vitro diagnostics industry
Market size and growth
In recent years, in the context of the rapid development of various new technologies and the gradual improvement of medical security policies in most countries,
the in vitro diagnostic industry has developed rapidly and has become one of the most active and fastest-growing industries in the medical market.
According to a research report by Kalorama Information, the global in vitro diagnostics market size will exceed US$127.4 million in 2022. It is estimated that as the
aging of the population progresses and global medical and health expenditures continue to increase, the global IVD market will maintain a compound annual
growth rate of approximately 2.5% in the future, and the global in vitro diagnostics market will reach US$140.0 million by 2027.
From the perspective of regional market distribution, according to a research report by Kalorama Information, the global in vitro diagnostic demand market is
mainly distributed in developed economic countries or regions such as North America, Europe, and Japan. Among them, the European and American market size is
US$98.4 billion, accounting for approximately 77%; The market size of the Asia-Pacific region is US$20.8 billion, accounting for approximately 16%.
The medical service systems in the above-mentioned major developed countries or regions are relatively complete, the in vitro diagnostic market has entered
a relatively stable and mature stage, the growth trend has slowed down, and the market size has shown a steady development trend. Although emerging markets
represented by China, India, Latin America, etc. currently account for a relatively small market share, due to their large population base, rapid economic growth,
and gradually increasing aging population, as well as government medical security investment and per capita medical consumption, With expenditures continuing
to grow, the in vitro diagnostics market is in a period of rapid growth and will become the fastest growing region in the global in vitro diagnostics market.
POCT is an important segment of the in vitro diagnostics market. As a testing method that uses portable analytical instruments or reagents to quickly obtain
results at the sampling site, it can obtain reliable diagnostic results quickly and immediately, forming a competitive advantage with traditional in vitro diagnostic
methods. complementary. From the perspective of testing items, the types of diseases detected by POCT include blood sugar, infectious diseases, inflammation,
cardiovascular and cerebrovascular, tumor markers, special proteins, pregnancy and drugs, etc. POCT can be used in clinical testing, major epidemic monitoring,
individual health management and other fields. , the specific usage scenarios include hospitals (such as emergency laboratories, hospital intensive care units and
laboratory departments), primary medical institutions (such as health centers, community outpatient clinics), prenatal care (such as pregnancy tests) and home
self-tests (such as blood pressure, blood sugar), etc.
Data from "Global Point of Care Testing Market Outlook 2022" shows that the global POCT market size is expected to reach US$30 billion in 2022, and the growth
rate of the global POCT market size is higher than the average growth rate of the global in vitro diagnostic market size. POCT has become an important
development direction and trend in the future in vitro diagnostic industry and has broad market growth space.
Infectious disease detection is an important application field of POCT products. POCT infectious disease detection products are mainly products for grassroots
on-site screening and rapid detection of various common infectious diseases and major infectious diseases, including AIDS, syphilis, viral hepatitis (hepatitis A) ,
hepatitis B, hepatitis C, hepatitis E), malaria and other infectious diseases rapid detection products and C-reactive protein (CRP) rapid quantitative detection
system for identifying bacterial or viral infections.
Infectious diseases are an important burden on public health and economic stability. With the globalization of economy and trade, the exchange of people and
goods between countries and regions has become increasingly frequent, and the incidence of infectious diseases is on the rise. POCT infectious disease detection
products can significantly improve the monitoring capabilities of infectious diseases, especially in areas such as Africa and Asia where medical infrastructure is
not widespread and complete. POCT infectious disease detection products can assist doctors in diagnosing and treating patients in a timely and accurate manner.
Reduce the possibility of disease transmission among the population and improve local medical standards. As the frequency and harm of some major infectious
disease outbreaks increase, many countries have increased their efforts to prevent and monitor major infectious diseases. POCT products have become a powerful
tool for preventing and monitoring infectious diseases.
In recent years, the global market size of POCT infectious disease detection products has grown from US$935 million in 2015 to US$1.43 billion in 2019, maintaining
a continuous growth trend. It is expected that the global market capacity of POCT infectious disease detection products will reach US$1.73 billion in 2021. . Due to
seasonal factors and other factors, infectious diseases such as influenza will break out to varying degrees in different parts of the world every year. At the same time,
with the frequent movement of international populations, some emerging infectious diseases still pose serious threats to countries around the world. POCT infectious
disease detection products Demand will continue to exist and maintain steady growth. POCT products will continue to be widely used in infectious disease prevention
and screening due to their advantages such as convenient operation and low cost, and the future market prospects are broad.
